Questions Regarding the Randomized Phase II Trial of Defactinib as Maintenance Therapy in Malignant Pleural Mesothelioma Reply

2019-09-01

Journal of Clinical Oncology , Volume 37 - Issue 25 p. 2294- +

Additional Metadata
Persistent URL	doi.org/10.1200/jco.19.01208, hdl.handle.net/1765/121020
Journal	Journal of Clinical Oncology
Organisation	Department of Pulmonology
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Fennell, D.A., Taylor, P., Gilligan, D., Nakano, Y., Scherpereel, A, Pavlakis, N., … Baas, P. (2019). Questions Regarding the Randomized Phase II Trial of Defactinib as Maintenance Therapy in Malignant Pleural Mesothelioma Reply. Journal of Clinical Oncology, 37(25), 2294–+. doi:10.1200/jco.19.01208

Publication